Advertisement

Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells

Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans-Ulrich Klein, Sylwia Flis, Grazyna Hoser, Thoralf Lange, Margaret Nieborowska-Skorska, Jacqueline Maier, Linda Kerstiens, Mateusz Koptyra, Martin C. Müller, Hardik Modi, Tomasz Stoklosa, Ilona Seferynska, Ravi Bhatia, Tessa L. Holyoake, Steffen Koschmieder and Tomasz Skorski

Article Information

Citation 
vol. 121 no. 20 4175-4183
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted November 15, 2012
  • Accepted March 23, 2013
  • Published online May 16, 2013.

Article Versions


Contributors 
  • Elisabeth Bolton-Gillespie, 1Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA;
  • Mirle Schemionek, 2Department of Medicine (Oncology, Hematology, and Stem Cell Transplantation), University Medical Center of Aachen, Aachen, Germany;
  • Hans-Ulrich Klein, 3Institute of Medical Informatics, University of Münster, Münster, Germany;
  • Sylwia Flis, 1Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA;
  • Grazyna Hoser, 4Department of Clinical Cytology, Medical Center for Postgraduate Education, Warsaw, Poland;
  • Thoralf Lange, 5Abteilung für Hämatologie, Onkologie, Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany;
  • Margaret Nieborowska-Skorska, 1Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA;
  • Jacqueline Maier, 5Abteilung für Hämatologie, Onkologie, Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany;
  • Linda Kerstiens, 6Department of Hematology/Oncology, University of Münster, Münster, Germany;
  • Mateusz Koptyra, 1Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA;
  • Martin C. Müller, 7Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany;
  • Hardik Modi, 8Division of Hematopoietic Stem Cell and Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA;
  • Tomasz Stoklosa, 9Department of Immunology, Medical University of Warsaw, Warsaw, Poland;
  • Ilona Seferynska, 10Department of Hematology, Institute of Hematology and Blood Transfusion, Warsaw, Poland;
  • Ravi Bhatia, 8Division of Hematopoietic Stem Cell and Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA;
  • Tessa L. Holyoake, 11Paul O’Gorman Leukemia Research Centre, University of Glasgow, Glasgow, United Kingdom; and
  • Steffen Koschmieder, 2Department of Medicine (Oncology, Hematology, and Stem Cell Transplantation), University Medical Center of Aachen, Aachen, Germany;
  • Tomasz Skorski, 1Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA; 12Fels Institute for Cancer Research and Molecular Biology, School of Medicine, Temple University, Philadelphia, PA

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output